AMERIPRISE FINANCIAL INC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,977,813
-$1,011,335 QoQ
Shares Held
171,529
-1.4% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 55%
None 45%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. SUPN ranks #14 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,977,813 | 171,529 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,989,148 | 173,905 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,997,041 | 181,027 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,760,623 | 183,315 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,458,475 | 173,175 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,825,400 | 452,684 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,281,437 | 450,261 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,025,994 | 546,055 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,097,994 | 564,411 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,315,469 | 566,270 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,197,775 | 559,702 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $15,687,853 | 569,019 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,892,462 | 595,225 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,594,336 | 678,839 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $24,908,003 | 698,290 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $26,861,904 | 793,557 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,860,734 | 825,060 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $27,385,220 | 847,315 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,066,563 | 825,328 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,389,944 | 839,518 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,731,789 | 803,241 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $20,027,097 | 764,977 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,997,158 | 755,054 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,394,979 | 690,738 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $15,158,318 | 638,245 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,091,422 | 783,292 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||